Phenolic Compounds from a Sex-Gender Perspective

Recent Advances in Polyphenol Research

Volumn 4, Issue , 2014, Pages 327-339

  Campesi, Ilaria ^a   Romani, Annalisa ^b   Marino, Maria ^c   Franconi, Flavia ^d  

^a NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c ROMA TRE UNIVERSITY   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

Author keywords

Health; Phenolic compound; Sex gender

Indexed keywords

BIOCHEMISTRY; DIETARY SUPPLEMENTS; HEALTH; NUTRITION; PHENOLS;

BIOACTIVE COMPOUNDS; CARDIO-VASCULAR DISEASE; CHEMICAL MATERIALS; HUMAN ORGANISMS; MOLECULAR LEVELS; PHENOLIC COMPOUNDS; PREVENTIVE ACTION; SEX-GENDER;

DISEASES;

EID: 84976384138     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118329634.ch10     Document Type: Chapter

References (106)

1. Al-Rejaie, S.S., Abuohashish, H.M., Alkhamees, O.A., et al. (2012) Gender difference following high cholesterol diet induced renal injury and the protective role of rutin and ascorbic acid combination in Wistar albino rats. Lipids in Health and Disease, 11, 41.
2. Al-Windi, A., Elmfeldt, D. & Svardsudd, K. (2000) The relationship between age, gender, well-being and symptoms, and the use of pharmaceuticals, herbal medicines and self-care products in a Swedish municipality. European Journal of Clinical Pharmacology, 56, 311-317.
3. Alonso, A. & Martinez-Gonzalez, M.A. (2004) Olive oil consumption and reduced incidence of hypertension: the SUN study. Lipids, 39, 1233-1238.
4. Ambrosini, G., Romani, A., Scazzocchio, B., et al. (2012) Sex-gender influences the expression of antioxidant/detoxifying enzyme induced by extra rirgin olive oil extracts in rat vascular smooth muscle cells. In: XXVIth International Conference on Polyphenols, July, 23-26, 2012, Florence, Italy (edsV. Lattanzio, N.Mulinacci, P. Pinelli A. Romani), Vol. 2, pp. 437-438, Abstract T4.03. University of Florence, Florence.
5. Anderson, J.W., Johnstone, B.M. & Cook-Newell, M.E. (1995) Meta-analysis of the effects of soy protein intake on serum lipids. The New England Journal of Medicine, 333, 276-282.
6. Andreadi, C.K., Howells, L.M., Atherfold, P.A. & Manson, M.M. (2006) Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappaB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Molecular Pharmacology, 69, 1033-1040.
7. Azadbakht, L., Kimiagar,M., Mehrabi, Y., et al. (2007) Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. The American Journal of Clinical Nutrition, 85, 735-741.
8. Bao, Y. & Fenwick, R. (2004) Phytochemicals in Health and Disease. Marcel Dekker, New York.
9. Beecher, G.R. (2003) Overview of dietary flavonoids: nomenclature, occurrence and intake. Journal of Nutrition, 133, 3248S-3254S.
10. Bises, G., Bajna, E., Manhardt, T., et al. (2007) Gender-specific modulation of markers for premalignancy by nutritional soy and calcium in the mouse colon. Journal of Nutrition, 137, 211S-215S.
11. Blair, R.M., Appt, S.E., Bennetau-Pelissero, C., et al. (2002) Dietary soy and soy isoflavones have gender-specific effects on plasma lipids and isoflavones in golden Syrian f(1)b hybrid hamsters. Journal of Nutrition, 132, 3585-3591.
12. Bock, K.W. (2012) Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factors. Biochemical Pharmacology, 84, 1000-1006.
13. Boudikova, B., Szumlanski, C., Maidak, B. & Weinshilboum, R. (1990) Human liver catechol-Omethyltransferase pharmacogenetics. Clinical Pharmacology & Therapeutics, 48, 381-389.
14. Brunelleschi, S., Bardelli, C.,Amoruso, A., et al. (2007) Minor polar compounds extra-virgin olive oil extract (MPC-OOE) inhibits NF-kappa B translocation in human monocyte/macrophages. Pharmacological Research, 56, 542-549.
15. Bulzomi, P. & Marino, M. (2011) Environmental endocrine disruptors: does a sex-related susceptibility exist? Frontiers in Bioscience, 16, 2478-2498.
16. Cassidy, A., Brown, J.E., Hawdon, A., et al. (2006) Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. Journal of Nutrition, 136, 45-51.
17. Cheng, S.Y., Shaw, N.S., Tsai, K.S. & Chen, C.Y. (2004) The hypoglycemic effects of soy isoflavones on postmenopausal women. Journal of Women's Health (Larchmt), 13, 1080-1086.
18. Chun, O.K., Chung, S.J. & Song, W.O. (2007) Estimated dietary flavonoid intake and major food sources of U.S. adults. Journal of Nutrition, 137, 1244-1252.
19. Coldham, N.G. & Sauer,M.J. (2000) Pharmacokinetics of [(14)C]Genistein in the rat: gender-related differences, potential mechanisms of biological action, and implications for human health. Toxicology and Applied Pharmacology, 164, 206-215.
20. Day, A.J., Bao, Y., Morgan, M.R. & Williamson, G. (2000) Conjugation position of quercetin glucuronides and effect on biological activity. Free Radical Biology & Medicine, 29, 1234-1243.
21. di Masi, A., De Marinis, E., Ascenzi, P. & Marino, M. (2009) Nuclear receptors CAR and PXR: molecular, functional, and biomedical aspects. Molecular Aspects of Medicine, 30, 297-343.
22. Diplock, A.T. (1999) Scientific concepts of functional foods in Europe. Consensus document. British Journal of Nutrition, 81, Suppl. 1, S1-27.
23. Dixon, R.A. & Pasinetti, G.M. (2010) Flavonoids and isoflavonoids: from plant biology to agriculture and neuroscience. Plant Physiology, 154, 453-457.
24. Doerge, D.R. & Sheehan, D.M. (2002) Goitrogenic and estrogenic activity of soy isoflavones. Environmental Health Perspectives, 110, Suppl. 3, 349-353.
25. Doyon, M. & Labrecque, J. (2008) Functional foods: a conceptual definition. British Food Journal, 110, 1133-1149.
26. Durante, K.M., Whitmore, B., Jones, C.A. & Campbell, N.R. (2001) Use of vitamins, minerals and herbs: a survey of patients attending family practice clinics. Clinical & Investigative Medicine, 24, 242-249.
27. Eisenberg, D.M., Davis, R.B., Ettner, S.L., et al. (1998) Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. Journal of the American Medical Association, 280, 1569-1575.
28. Fennell, D. (2004) Determinants of supplement usage. Preventive Medicine, 39, 932-939.
29. Finking, G., Wohlfrom, M., Lenz, C., et al. (1999) The phytoestrogens Genistein and Daidzein, and 17 beta-estradiol inhibit development of neointima in aortas from male and female rabbits in vitro after injury. Coronary Artery Disease, 10, 607-615.
30. Fraga, C.G., Galleano, M., Verstraeten, S.V. & Oteiza, P.I. (2010) Basic biochemical mechanisms behind the health benefits of polyphenols. Molecular Aspects of Medicine, 31, 435-445.
31. Franconi, F., Brunelleschi, S., Steardo, L. & Cuomo, V. (2007) Gender differences in drug responses. Pharmacological Research, 55, 81-95.
32. Franconi, F., Carru, C., Malorni, W., et al. (2011a) The effect of sex/gender on cardiovascular pharmacology. Current Pharmaceutical Design, 17, 1095-1107.
33. Franconi, F., Carru, C., Spoletini, I., et al. (2011b)AGENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics. Therapeutic Delivery, 2, 1437-1453.
34. Franconi, F., Sanna, M., Straface, E., et al. (2011c) Pharmacokinetics and pharmacodynamics: the role of sex and gender. In: Sex and Gender Aspects in Clinical Medicine (eds S. Oertelt-Prigione & V. Regitz-Zagrosek), pp. 183-194. Springer-Verlag, London.
35. Fujioka,M., Sudo,Y.,Okumura, M., et al. (2007) Differential effects of isoflavones on bone formation in growing male and female mice. Metabolism, 56, 1142-1148.
36. Gallagher, C.J., Balliet, R.M., Sun, D., et al. (2010) Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity. Drug Metabolism and Disposition, 38, 2204-2209.
37. Galluzzo, P. Marino, M. (2006) Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities. Genes & Nutrition, 1, 161-176.
38. Gandhi, M., Aweeka, F., Greenblatt, R.M. & Blaschke, T.F. (2004) Sex differences in pharmacokinetics and pharmacodynamics. Annual Review of Pharmacology and Toxicology, 44, 499-523.
39. Gubbins, P.O., Gurley, B.J.,Williams, D.K., et al. (2008) Examining sex-related differences in enteric itraconazole metabolism in healthy adults using grapefruit juice. European Journal of Clinical Pharmacology, 64, 293-301.
40. Haines, C.D., Harvey, P.A. & Leinwand, L.A. (2012a) Estrogens mediate cardiac hypertrophy in a stimulus-dependent manner. Endocrinology, 153, 4480-4490.
41. Haines, C.D., Harvey, P.A., Luczak, E.D., et al. (2012b) Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease. Endocrinology, 153, 4470-4479.
42. Halliwell, B. (2007) Dietary polyphenols: good, bad, or indifferent for your health? Cardiovascular Research, 73, 341-347.
43. Handschin, C. & Meyer, U.A. (2003) Induction of drug metabolism: the role of nuclear receptors. Pharmacological Reviews, 55, 649-673.
44. Ho, S.C.,Woo, J.L., Leung, S.S., et al. (2000) Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. Journal of Nutrition, 130, 2590-2593.
45. Hooper, L., Ryder, J.J., Kurzer, M.S., et al. (2009) Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Human Reproduction Update, 15, 423-440.
46. Institute of Medicine (2011) The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. National Academies Press, Washington, DC.
47. Jakobs, S., Fridrich, D., Hofem, S., et al. (2006) Natural flavonoids are potent inhibitors of glycogen phosphorylase. Molecular Nutrition & Food Research, 50, 52-57.
48. Jenkins, D.J., Kendall, C.W., Jackson, C.J., et al. (2002) Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. The American Journal of Clinical Nutrition, 76, 365-372.
49. Juniewicz, P.E., PallanteMorell, S.,Moser, A. & Ewing, L.L. (1988) Identification of phytoestrogens in the urine of male dogs. Journal of Steroid Biochemistry, 31, 987-994.
50. Kahle, K., Kempf, M., Schreier, P., et al. (2010) Intestinal transit and systemic metabolism of apple polyphenols. European Journal of Nutrition, 50, 507-522.
51. Kane, M.O., Anselm, E., Rattmann, Y.D., et al. (2009) Role of gender and estrogen receptors in the rat aorta endothelium-dependent relaxation to red wine polyphenols. Vascular Pharmacology, 51, 140-146.
52. Kaufman, D.W., Kelly, J.P., Rosenberg, L., et al. (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. Journal of the American Medical Association, 287, 337-344.
53. Kelly, G.E., Nelson, C., Waring, M.A., et al. (1993) Metabolites of dietary (soya) isoflavones in human urine. Clinica Chimica Acta, 223, 9-22.
54. Kennedy, J. (2005) Herb and supplement use in the US adult population. Clinical Therapeutics, 27, 1847-1858.
55. Kirkman, L.M., Lampe, J.W., Campbell, D.R., et al. (1995) Urinary lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets. Nutrition and Cancer, 24, 1-12.
56. Kretschmer, X.C. & Baldwin, W.S. (2005) CAR and PXR: xenosensors of endocrine disrupters? Chemico-Biological Interactions, 155, 111-128.
57. Kulkarni, K.H., Yang, Z., Niu, T. & Hu, M. (2012) Effects of estrogen and estrus cycle on pharmacokinetics, absorption, and disposition of genistein in female sprague-dawley rats. Journal of Agricultural and Food Chemistry, 60, 7949-7956.
58. Lampe, J.W., Karr, S.C., Hutchins, A.M. & Slavin, J.L. (1998) Urinary equol excretion with a soy challenge: influence of habitual diet. Proceedings of the Society for Experimental Biology and Medicine, 217, 335-339.
59. Li, Y., Ross-Viola, J.S., Shay, N.F., et al. (2009) Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner. Journal of Nutrition, 139, 898-904.
60. Liew, R., Stagg, M.A., Chan, J., et al. (2004) Gender determines the acute actions of genistein on intracellular calcium regulation in the guinea-pig heart. Cardiovascular Research, 61, 66-76.
61. Lu, L.J. & Anderson, K.E. (1998) Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans. The American Journal of Clinical Nutrition, 68, 1500S-1504S.
62. Lu, L.J., Grady, J.J., Marshall, M.V., et al. (1995) Altered time course of urinary daidzein and genistein excretion during chronic soya diet in healthy male subjects. Nutrition and Cancer, 24, 311-323.
63. Lu, L.J., Lin, S.N., Grady, J.J., et al. (1996) Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure. Nutrition and Cancer, 26, 289-302.
64. Lundh, T. (1995) Metabolism of estrogenic isoflavones in domestic animals. Proceedings of the Society for Experimental Biology and Medicine, 208, 33-39.
65. Manach, C., Morand, C., Crespy, V., et al. (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Letters, 426, 331-336.
66. Manach, C., Scalbert, A., Morand, C., et al. (2004) Polyphenols: food sources and bioavailability. The American Journal of Clinical Nutrition, 79, 727-747.
67. Manach, C.,Williamson, G.,Morand, C., et al. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition, 81, 230S-242S.
68. Manson, M.M. (2003) Cancer prevention-the potential for diet to modulate molecular signalling. Trends in Molecular Medicine, 9, 11-18.
69. Marino, M. & Bulzomi, P. (2009) Mechanisms at the root of flavonoid action in cancer: a step toward solving the Rubik's cube. In: Flavonoids: Biosynthesis, Biological Effects and Dietary Sources (ed. R.B. Keller), pp. 231-248. Nova Science, New York.
70. Marino, M., Masella, R., Bulzomi, P., et al. (2011) Nutrition and human health from a sex-gender perspective. Molecular Aspects of Medicine, 32, 1-70.
71. Maskarinec, G., Aylward, A.G., Erber, E., et al. (2008) Soy intake is related to a lower body mass index in adult women. European Journal of Nutrition, 47, 138-144.
72. Meijerman, I., Beijnen, J.H. & Schellens, J.H. (2006) Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist, 11, 742-752.
73. Moon, Y.J.,Wang, X.Morris, M.E. (2006) Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicology in Vitro, 20, 187-210.
74. Moskaug, J.O., Carlsen, H., Myhrstad, M.C. & Blomhoff, R. (2005) Polyphenols and glutathione synthesis regulation. The American Journal of Clinical Nutrition, 81, 277S-283S.
75. Nagata, C., Takatsuka, N., Kurisu, Y. & Shimizu, H. (1998) Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. Journal of Nutrition, 128, 209-213.
76. Nagata, C., Shimizu, H., Takami, R., et al. (2003) Association of blood pressure with intake of soy products and other food groups in Japanese men and women. Preventive Medicine, 36, 692-697.
77. The Office of Dietary Supplements (1994) Dietary Supplement Health and Education Act of 1994. National Institutes of Health, Bethesda, MD.
78. Ohta, A., Uehara, M., Sakai, K., et al. (2002) A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice. Journal of Nutrition, 132, 2048-2054.
79. Pan, A., Franco, O.H., Ye, J., et al. (2008) Soy protein intake has sex-specific effects on the risk of metabolic syndrome in middle-aged and elderly Chinese. Journal of Nutrition, 138, 2413-2421.
80. Penza, M., Montani, C., Romani, A., et al. (2006) Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology, 147, 5740-5751.
81. Perez-Vizcaino, F. & Duarte, J. (2010) Flavonols and cardiovascular disease. Molecular Aspects of Medicine, 31, 478-494.
82. Ramos, S. (2008) Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Molecular Nutrition & Food Research, 52, 507-526.
83. Regitz-Zagrosek, V. (2012). Sex and Gender Differences in Pharmacology. Handbook of Experimental Pharmacology, Vol. 214. Springer-Verlag, Berlin, Heidelberg.
84. Romani, A., Vona, R., Masella, R., et al. (2012). Identification and characterization of Tuscan extra-virgin olive oil extracts and their biological activity in rat VSMC. In: XXVIth International Conference on Polyphenols, July, 23-26, 2012, Florence, Italy (eds V. Lattanzio, N. Mulinacci, P. Pinelli & A. Romani), Vol. 2, pp. 563-564, Abstract T4.66. University of Florence, Florence.
85. Rowland, I.R., Wiseman, H., Sanders, T.A., et al. (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutrition and Cancer, 36, 27-32.
86. Rowland, I., Faughnan, M., Hoey, L., et al. (2003) Bioavailability of phyto-oestrogens. British Journal of Nutrition, 89, Suppl. 1, S45-S58.
87. Sacks, F.M., Lichtenstein, A., Van Horn, L., et al. (2006) Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the American Heart Association Nutrition Committee. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1689-1692.
88. Satsu, H., Hiura, Y., Mochizuki, K., et al. (2008) Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals. Journal of Agricultural and Food Chemistry, 56, 5366-5373.
89. Scalbert, A. & Williamson, G. (2000) Dietary intake and bioavailability of polyphenols. Journal of Nutrition, 130, 2073S-2085S.
90. Setchell, K.D., Brown, N.M. & Lydeking-Olsen, E. (2002) The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. Journal of Nutrition, 132, 3577-3584.
91. Singh, S.R. & Levine, M.A. (2006) Natural health product use in Canada: analysis of the National Population Health Survey. The Canadian Journal of Clinical Pharmacology, 13, e240-250.
92. Siow, R.C. & Mann, G.E. (2010) Dietary isoflavones and vascular protection: activation of cellular antioxidant defenses by SERMs or hormesis? Molecular Aspects of Medicine, 31, 468-477.
93. Stauffer, B.L., Konhilas, J.P., Luczak, E.D. & Leinwand, L.A. (2006) Soy diet worsens heart disease in mice. The Journal of Clinical Investigation, 116, 209-216.
94. Tsao, R. (2010) Chemistry and biochemistry of dietary polyphenols. Nutrients, 2, 1231-1246.
95. Virgili, F. & Marino, M. (2008) Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity. Free Radical Biology & Medicine, 45, 1205-1216.
96. Wang, H., Li, H., Moore, L.B., et al. (2008) The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptor. Molecular Endocrinology, 22, 838-857.
97. Welty, F.K., Lee, K.S., Lew, N.S. & Zhou, J.R. (2007) Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Archives of Internal Medicine, 167, 1060-1067.
98. World Health Organization (2004) Food and Health in Europe: A New Basis for Action (eds A. Robertson, C. Tirado, T. Lobstein, et al.), WHO Regional Publications, European series, No. 96. WHO Regional Office for Europe, Copenhagen.
99. Wiseman, H., Casey, K., Bowey, E.A., et al. (2004) Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. The American Journal of Clinical Nutrition, 80, 692-699.
100. Wizemann, T.M. & Pardue, M.L. (2001) Exploring the Biological Contributions to Human Health: Does Sex Matter? National Academy Press, Washington, DC.
101. Wu, B., Kulkarni, K., Basu, S., et al. (2011) First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. Journal of Pharmaceutical Sciences, 100, 3655-3681.
102. Wung, B.S., Hsu, M.C., Wu, C.C. & Hsieh, C.W. (2005) Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation. Life Sciences, 78, 389-397.
103. Xiao, Z.P., Peng, Z.Y., Peng, M.J., et al. (2011) Flavonoids health benefits and their molecular mechanism. Mini-Reviews in Medicinal Chemistry, 11, 169-177.
104. Xu, X., Harris, K.S., Wang, H.J., et al. (1995) Bioavailability of soybean isoflavones depends upon gut microflora in women. Journal of Nutrition, 125, 2307-2315.
105. Yao, R., Yasuoka, A., Kamei, A., et al. (2011) Polyphenols in alcoholic beverages activating constitutive androstane receptor CAR. Bioscience, Biotechnology, and Biochemistry, 75, 1635-1637.
106. Zhang, B., Chen, Y.M., Huang, L.L., et al. (2008) Greater habitual soyfood consumption is associated with decreased carotid intima-media thickness and better plasma lipids in Chinese middle-aged adults. Atherosclerosis, 198, 403-411.